|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/28 | (2006.01) |
| A61K 31/155 | (2013.01) | ||
| A61K 31/155 | (2006.01) | ||
| A61K 38/28 | (2013.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 38/26 | (2013.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 3/10 | (2018.01) |
| (11) | Patento numeris | 3268029 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16711171.5 |
| Europos patento paraiškos padavimo data | 2016-03-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-01-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-04-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/055267 |
| Data | 2016-03-11 |
| (87) | Numeris | WO 2016/146514 |
| Data | 2016-09-22 |
| (30) | Numeris | Data | Šalis |
| 15159064 | 2015-03-13 | EP |
| (72) |
ROY, Christine , FR
SOUHAMI, Elisabeth , FR
DEMIL, Nacima , FR
YE, Jenny , US
|
| (73) |
Sanofi-Aventis Deutschland GmbH ,
Brüningstraße 50, 65929 Frankfurt,
DE
|
| (54) | TREATMENT OF TYPE 2 DIABETES MELLITUS PATIENTS |
| TREATMENT OF TYPE 2 DIABETES MELLITUS PATIENTS |